本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Acumen Pharmaceuticals, Inc.

2.92
+0.06002.10%
盤後2.930.0100+0.34%19:30 EDT
成交量:31.83萬
成交額:92.48萬
市值:2.11億
市盈率:-1.78
高:2.99
開:2.93
低:2.84
收:2.86
52周最高:3.60
52周最低:1.21
股本:7,221.28萬
流通股本:3,704.59萬
量比:0.81
換手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-1.6370
每股收益(LYR):-2.0035
淨資產收益率:-120.50%
總資產收益率:-45.77%
市淨率:3.68
市盈率(LYR):-1.46

資料載入中...

2022/03/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/07

重要事件披露

8-K - Current report
2021/07/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/16

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/09

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/09

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933